Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Sultana

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Expert Review of Clinical Pharmacology|March 17, 2020
The potential role of big data in the detection of adverse drug reactionsJanet Sultana, Gianluca Trifirò
Drug Safety|August 26, 2017
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging SourcesGianluca Trifirò, Janet Sultana, Andrew Bate
Journal of Pharmacology & Pharmacotherapeutics|December 19, 2013
Clinical and economic burden of adverse drug reactionsJanet Sultana, Paola Cutroneo, Gianluca Trifirò
Drug Safety|May 27, 2014
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studiesGianluca Trifiró, Janet Sultana, Edoardo Spina
Expert Opinion on Drug Metabolism & Toxicology|March 5, 2015
Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safetyJanet Sultana, Edoardo Spina, Gianluca Trifirò
Frontiers in Pharmacology|November 24, 2022
Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugsWu Zhong, Vincenzo Brancaleone, Janet Sultana
Expert Opinion on Drug Safety|November 29, 2014
Antipsychotic use in elderly patients and the risk of pneumoniaGiovanni Gambassi, Janet Sultana, Gianluca Trifirò
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Frontiers in Public Health|October 31, 2022
Editorial: Overcoming boundaries in public health: Advances in international and global healthIppazio C Antonazzo, Janet Sultana, Pietro Ferrara
Expert Review of Clinical Pharmacology|March 22, 2023
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?Gabriella Guo Sciriha, Janet Sultana, Joseph Borg
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Expert Review of Clinical Pharmacology|March 17, 2020
The potential role of big data in the detection of adverse drug reactionsJanet Sultana, Gianluca Trifirò
Drug Safety|August 26, 2017
From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging SourcesGianluca Trifirò, Janet Sultana, Andrew Bate
Journal of Pharmacology & Pharmacotherapeutics|December 19, 2013
Clinical and economic burden of adverse drug reactionsJanet Sultana, Paola Cutroneo, Gianluca Trifirò
Drug Safety|May 27, 2014
Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studiesGianluca Trifiró, Janet Sultana, Edoardo Spina
Expert Opinion on Drug Metabolism & Toxicology|March 5, 2015
Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safetyJanet Sultana, Edoardo Spina, Gianluca Trifirò
Frontiers in Pharmacology|November 24, 2022
Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugsWu Zhong, Vincenzo Brancaleone, Janet Sultana
Expert Opinion on Drug Safety|November 29, 2014
Antipsychotic use in elderly patients and the risk of pneumoniaGiovanni Gambassi, Janet Sultana, Gianluca Trifirò
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Frontiers in Public Health|October 31, 2022
Editorial: Overcoming boundaries in public health: Advances in international and global healthIppazio C Antonazzo, Janet Sultana, Pietro Ferrara
Expert Review of Clinical Pharmacology|March 22, 2023
Pharmacological treatment for transforming growth factor beta induced corneal dystrophies: what is the way forward?Gabriella Guo Sciriha, Janet Sultana, Joseph Borg
Pageof 9